HumeCare+ vs bmiMD: Bundled support vs low-cost tirzepatide
HumeCare+ vs bmiMD compares a bundled GLP-1 protocol with muscle-preserving additives and body-composition scans (HumeCare+) to a lower-cost, multi-term tirzepatide subscription option (bmiMD). Early verdict: choose HumeCare+ if you want clinician-led protocols, built-in glycine and B vitamins, and monthly body composition tracking; choose bmiMD if your priority is the lowest long-term tirzepatide price with multi-month billing options.
See HumeCare+ protocol and pricing
How these services differ at a glance
Both vendors offer clinician-reviewed access to compounded GLP-1 products and both state that compounded medications are not FDA-reviewed. The most distinctive differences are: pricing and billing flexibility; bundled supportive ingredients and body composition tracking; refund and eligibility promises; and who sets dosing and monitoring details.
Price and billing: monthly rates vs multi-month savings
HumeCare+ lists semaglutide starting at $199 per month and a tirzepatide plus B12 and glycine protocol at $299 per month. bmiMD lists tirzepatide options with four billing choices: $179 month-to-month, $159 per month for three months, $149 per month for six months, and $139 per month for a 12-month plan, with free shipping on subscriptions. If lowest monthly equivalent over a year matters, bmiMD’s 12-month plan shows the lowest rate but requires a longer commitment.
Compare bmiMD tirzepatide billing options
Bundled clinical support and monitoring
HumeCare+ positions itself as a protocol, not just a prescription. It pairs physician-prescribed compounded semaglutide or tirzepatide with glycine, vitamins B6 and B12 built into the formulation, an app for tracking, unlimited clinician access, and monthly body-composition scans that report fat versus lean mass. bmiMD focuses on compounded tirzepatide with online refills, free subscription shipping, and 24/7 clinician access, without the same advertised built-in supplements or routine body-composition scanning.
View HumeCare+ support features
Refunds, promises, and eligibility
HumeCare+ advertises a 10%-or-your-money-back promise over six months, with eligibility and full terms to verify directly with the company. The company also notes results are based on an internal analysis of 6,846 members and that individual results may vary. bmiMD states a 100% refundable charge if a person is not eligible for the program and emphasizes plan-specific total price details that should be confirmed before purchase. Both providers include qualifying language and require a licensed clinician to determine medical appropriateness.
Regulatory and safety qualifiers
Both HumeCare+ and bmiMD offer compounded medications and clearly state that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality. HumeCare+ also lists that compounded medications are dispensed from U.S. pharmacies licensed and inspected by state Boards of Pharmacy. HumeCare+ warns GLP-1 drugs carry serious risks, including a boxed warning for thyroid C-cell tumors. bmiMD notes preparation in state-licensed pharmacies and verification steps in labs as captured on its landing page.
Direct comparison table
| Criteria | HumeCare+ | bmiMD |
|---|---|---|
| Primary medication options | Compounded semaglutide or tirzepatide with glycine and B vitamins | Compounded tirzepatide |
| Starting price (advertised) | Semaglutide from $199/mo; tirzepatide protocol $299/mo | Tirzepatide: $179/mo month-to-month; down to $139/mo on 12-month plan |
| Support and tracking | Monthly body-composition scans, app, unlimited clinician access | Online refills, 24/7 clinician access, free subscription shipping |
| Refund promise | 10%-or-money-back over six months (terms apply) | 100% refundable if not eligible for program |
| Commitment requirement | No long-term billing required; cancel anytime | Lowest rates require 6- or 12-month plan |
| Regulatory note | Compounded medications not FDA-reviewed | Compounded medications not FDA-reviewed |
Who controls dosing and clinical oversight
HumeCare+ states doses are set by your provider and offers continuous physician optimization and a U.S. care team. bmiMD also requires a licensed clinician to determine medical appropriateness and confirms ongoing verification practices to maintain target strength, but its messaging emphasizes billing flexibility and lab verification practices for compounded tirzepatide.
Check bmiMD clinician review and terms
Bottom line and how to choose
HumeCare+ vs bmiMD comes down to what you value: HumeCare+ is best for patients who want a bundled GLP-1 protocol with added glycine and B vitamins, monthly body-composition scans, an app, unlimited clinician access, and a 10%-or-money-back promise. bmiMD is best for people who prioritize lower long-term tirzepatide pricing via multi-month plans, free subscription shipping, and straightforward online refills. Both offer compounded medications and require clinician approval; both state compounded medications are not FDA-reviewed.
Select HumeCare+ if you want built-in supplements, body-composition tracking, and continuous clinician optimization.
Select bmiMD if your priority is the lowest monthly equivalent price for tirzepatide through a 6- or 12-month plan and free subscription shipping.